An exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast–ovarian cancer syndrome
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
An exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast–ovarian cancer syndrome ; volume:09 ; number:01 ; year:2020 ; pages:06-12
South Asian journal of cancer ; 09, Heft 01 (2020), 06-12
- Beteiligte Personen und Organisationen
-
Talreja, Vikas T.
Noronha, Vanita
Joshi, Amit
Patil, Vijay
Prabhash, Kumar
- DOI
-
10.4103/sajc.sajc_157_19
- URN
-
urn:nbn:de:101:1-2021021718041939441987
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 05:36 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Talreja, Vikas T.
- Noronha, Vanita
- Joshi, Amit
- Patil, Vijay
- Prabhash, Kumar
Ähnliche Objekte (12)
Treatment of advanced nonsmall cell lung cancer: First line, maintenance and second line – Indian consensus statement update
The changing landscape of hormonal therapy in castration-resistant prostate cancer
Thyroid cancer in Gardner’s syndrome: Case report and review of literature
Lung cancer in the Indian subcontinent
Chronic myeloid leukemia data from India
Confusion worse confounded
An exceptional response to nivolumab in relapsed and refractory malignant mesothelioma
Carcinomatous meningitis in non-small cell lung cancer: Palliation with intrathecal treatment
Lorlatinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience
Comparison of postoperative complications in advanced head and neck cancer patients receiving neoadjuvant chemotherapy followed by surgery versus surgery alone
Promoting of Oncology Training and Education in India: Lessons from our unique oncology continuing medical education project
Geriatric oncology: The need of the hour
Treatment of advanced nonsmall cell lung cancer: First line, maintenance and second line – Indian consensus statement update
The changing landscape of hormonal therapy in castration-resistant prostate cancer
Thyroid cancer in Gardner’s syndrome: Case report and review of literature
Lung cancer in the Indian subcontinent
Chronic myeloid leukemia data from India
Confusion worse confounded
An exceptional response to nivolumab in relapsed and refractory malignant mesothelioma
Carcinomatous meningitis in non-small cell lung cancer: Palliation with intrathecal treatment
Lorlatinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience
Comparison of postoperative complications in advanced head and neck cancer patients receiving neoadjuvant chemotherapy followed by surgery versus surgery alone
Promoting of Oncology Training and Education in India: Lessons from our unique oncology continuing medical education project
Geriatric oncology: The need of the hour
Treatment of advanced nonsmall cell lung cancer: First line, maintenance and second line – Indian consensus statement update
The changing landscape of hormonal therapy in castration-resistant prostate cancer
Thyroid cancer in Gardner’s syndrome: Case report and review of literature
Lung cancer in the Indian subcontinent
Chronic myeloid leukemia data from India
Confusion worse confounded
An exceptional response to nivolumab in relapsed and refractory malignant mesothelioma
Carcinomatous meningitis in non-small cell lung cancer: Palliation with intrathecal treatment
Lorlatinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience
Comparison of postoperative complications in advanced head and neck cancer patients receiving neoadjuvant chemotherapy followed by surgery versus surgery alone
Promoting of Oncology Training and Education in India: Lessons from our unique oncology continuing medical education project